Ligand · OAW
OAW · 2-amino-4-methyl-8-(1-methylethyl)-6-(1H-pyrazol-4-yl)pteridin-7(8H)-one
OAW, 2-amino-4-methyl-8-(1-methylethyl)-6-(1H-pyrazol-4-yl)pteridin-7(8H)-one (C13 H15 N7 O, 285.3 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the…
- Component
- OAW
- Formula
- C13 H15 N7 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
OAW in 2 structures; the first of them:
- 3OAW · 4-Methylpteridineones as Orally Active and Selective PI3K/mTOR Dual Inhibitors · OAW A1 · binds MET804, TRP812, ILE831, LYS833, ASP836, ASP841, TYR867, ILE879 and 9 more
- 3OAW · 4-methylpteridineones as orally active and selective PI3K/MTOR dual inhibitors · OAW A1 · binds MET804, TRP812, ILE831, LYS833, ASP836, ASP841, TYR867, ILE879 and 9 more
Residues it binds most
ILE 2, ASP 2, LYS 2, MET 2, ALA 2, GLU 2, PHE 2, TRP 2, TYR 2, VAL 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.